Cepheid Wins FDA Clearance for Hemorrhagic Fever Panel
Sunnyvale, California, USA, November 3, 2026 Cepheid, a Danaher company and a global leader in molecular diagnostics, has announced...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease solid tumors targeted therapy
Sunnyvale, California, USA, November 3, 2026 Cepheid, a Danaher company and a global leader in molecular diagnostics, has announced...
Brea, California, USA, November 3, 2026 Beckman Coulter Diagnostics, a Danaher company and global leader in clinical diagnostics, has...
Boston, Massachusetts, United States, October 28, 2026 Empatica, a company specialising in digital biomarkers and clinical-grade wearable technology, has...
GERMANTOWN, Md. and VENLO, Netherlands — September 28, 2026 QIAGEN N.V. announced that the U.S. Food and Drug Administration...
SEATTLE, Wash. — September 17, 2026 Adaptive Biotechnologies highlighted updates to the National Comprehensive Cancer Network (NCCN) Guidelines for...
Bagsværd, Denmark, September 18, 2026 Novo Nordisk has announced that the Committee for Medicinal Products for Human Use (CHMP)...
Basel, Switzerland, September 18, 2026 Roche has announced that the European Medicines Agency’s Committee for Medicinal Products for Human...
Boston, Massachusetts, U.S., September 18, 2026 ZBeats, a digital health and medical technology company focused on cardiac diagnostics, has...
Carlsbad, California, USA, September 17, 2026 Aptitude Medical Systems has announced that the U.S. Food and Drug Administration (FDA)...
Aurora, Colorado, U.S., September 10, 2026 University of Colorado Anschutz Medical Campus (CU Anschutz) has received U.S. Food and...
